C. Marando

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

S. M. Park, M. N. Duy, Le Tuan Linh, 2019, Lancet.

Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review

S. Ricci, A. Mengoni, M. Romoli, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.